Gemcitabine and XCT790, an ERRα inverse agonist, display a synergistic anticancer effect in pancreatic cancer

Pancreatic cancer (PC) is one of the most fatal and chemoresistant malignancies with a poor prognosis. The current therapeutic options for PC have not achieved satisfactory results due to drug resistance. Therefore, it is urgent to develop novel treatment strategies with enhanced efficacy. This stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shi-lei, Liang, Hai-bin, Yang, Zi-yi, Cai, Chen, Wu, Zi-you, Wu, Xiang-song, Dong, Ping, Li, Mao-lan, Zheng, Lei, Gong, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795805/
https://www.ncbi.nlm.nih.gov/pubmed/35165514
http://dx.doi.org/10.7150/ijms.68404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795805/
https://www.ncbi.nlm.nih.gov/pubmed/35165514
http://dx.doi.org/10.7150/ijms.68404

Ejemplares similares